


The Fund seeks to achieve long-term capital growth primarily through investment in US equities with growth characteristics.
| Name | % Net Assets |
|---|---|
| Allergan | 6.9% |
| 4.3% | |
| Mastercard | 4.0% |
| Visa | 3.9% |
| Cisco Systems | 3.8% |
| Qualcomm | 3.6% |
| Allergan | 3.6% |
| Amazon.Com | 3.4% |
| McDonalds | 3.3% |
| Covidien | 3.1% |
| Key | % Net Assets |
|---|---|
| 6.9% | |
| 4.3% | |
| 4.0% | |
| 3.9% | |
| 80.9% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 10/11/2008 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research